Buradasınız

Anasayfa » Content

Soğuk İlaçlar

Cold Medications

Journal Name:

  • Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2011

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Colds, coughs, and upper respiratory infections are common childhood illnesses. Cough and cold medications are marketed widely for relief of common cold symptoms. However, minimal data exist to support their effectiveness. Studies have failed to demonstrate a benefit of these medications for young children. In addition, adverse effects and overdosage associated with the administration of cough and cold preparations in children have been reported. We explore the toxities of cold medications, and suggest why physicians should be more vigilant about these drugs. Education of patients and parents about the potential risks of these products is needed.
Bookmark/Search this post with
Abstract (Original Language): 
Soğuk algınlığı, öksürük ve üst solunum yolu enfeksiyonları sık görülen çocukluk çağı hastalıklarıdır. Öksürük ve soğuk algınlığı ilaçları yaygın olarak soğuk algınlığı belirtilerini hafifletmek için pazarlanmaktadır. Ancak, etkinliklerini destekleyen çok az veri vardır. Küçük çocuklarda bu ilaçların bir yararını göstermek için yapılan çalışmalar başarısız olmuştur. Ayrıca, çocuklarda öksürük ve soğuk algınlığı preparatlarının yan etkileri ve doz aşımı rapor edilmiştir. Soğuk algınlığı ilaçlarının toksitelerini araştırdık ve bu ilaçlar hakkında hekimlerin neden daha fazla uyanık olmaları gerektiğini önerdik. Bu ürünlerin potensiyel riskleri hakkında hasta ve ebeveylerin de eğitimi gereklidir.
FULL TEXT (PDF): 
PDF icon arastirmax-soguk-ilaclar.pdf
  • 1
25-29
  • Turkish

REFERENCES

References: 

1. Pappas DE, Hayden GF, Hendley JO. Treating colds: keep it simple. Contemp Pediatr 1999; 16: 109-119.
2. Maiman LA, Becker MH, Katlic AW. Correlates of mothers' use ofmedications for their children. Soc Sci Med 1986;22:41-51.
3. Korppi M, Pietikainen M, Laurikainen K, Silvasti M. Antitussives in the treatment of acute transient cough in children. Acta Paediatr Scand 1991; 80: 969-971.
4. Stuijvenberg van M, Vos de S, Tjiang GCH, Steyerberg EW, Derksen-Lubsen G, Moll HA. Parents' fear regarding fever and febrile seizures. Acta Paediatr 1999; 88: 618-622.
5. Impicciatore P, Nannini S, Pandolfini C, Bonati M. Mother's knowledge of, attitudes toward, and management of fever in preschool in Italy. Prev Med 1998;27:268-273.
6. Smith MB, Feldman W. Over-the-counter cold medications: a critical review ofclinical trials between 1950 and 1991. JAMA 1993; 269: 2258-2263.
7. American Academy of Pediatrics, Committee on Drugs. Use ofcodeine and dextromethorphan-containing cough remedies in children. Pediatrics 1997; 99: 918-920.
8. Royal College ofGeneral Practitioners, Office of Population Censuses and Surveys, and Department of Health. Morbidity statistics from general practice. Fourth national study 1991-1992. London: HMSO Publications Center, 1992.
9. Kogan MD, Pappas G, Yu SM, Kotelchuck M. Over-the-counter medication use among U.S. preschool-age children. JAMA 1994; 272: 1025-1030.
10. Banks I. The NHS direct healthcare guide. London: Department ofHealth, 2001.
11. Department ofHealth. Pharmacy in the future-implanting the NHS plan. A programme for pharmacy in the National Health Service. London: Department ofHealth, 2000.
12. Vernacchio L, Kelly JP, Kaufman DW, Mitchell AA. Pseudoephedrine use among US children, 1999-2006: results from the Slone survey. Pediatrics 2008;122: 1299-1304.
13. Sutter AI, Lemiengre M, Campbell H, Mackinnon HF. Antihistamines for the common cold. Cochrane Database Syst.Rev 2003;3: CD001267.
14. Isbister GK, Prior F, Kilham HA. Restricting cough and cold medicines in children. J Paediatr Child Health 2010 Jun 27 (Epub ahead ofprint)
15. Nine JS, Rund CR. Fatality from diphenhydramine monointoxication: a case report and review ofthe infant, pediatric, and adult literature. Am J Forensic Med Pathol 2006;27: 36-41.
16. Heikkinen T, Jarvinen A. The common cold. Lancet 2003; 361: 51-59.
17. Lee AC, Chan R, So KT. A case ofprobable codeine poisoning in a young infant after the use ofaproprietary cough and cold medicine. Hong Kong Med J 2004; 10: 285-287.
18. Kelly LF. Pediatric cough and cold preparations. Pediatr Rev2004;25: 115-123.
19. Taverner D, Latte J. Nasal decongestants for the common cold. Cochrane Database Syst.Rev. 2007;1: CD001953.
20. Hatton RC, Winterstein AG, McKelvey RP, Shuster J, Hendeles L. Efficacy and safety oforal phenylephrine: systematic review and meta-analysis. Ann Pharmacother 2007;41: 381-390.
21. Anonymous. Cough medications in children. Drug TherBull 1999; 37: 19-21.
22. Kernan WN, Viscoli CM, Brass LM, et al. Phenylpropanolamine and the risk ofhemorrhagic stroke.NEnglJMed2000; 343: 1826-1832.
23. Food and Drug Administration. Public Health Advisory Subject: Phenylpropanolamine. Available on line at:www.fdagov/cder/drug/mfopage/ppa/advisory.htm.
24. Clemens CJ, Taylor JA, Almquist JR, Quinn HC, Mehta A, Naylor GS. Is an antihistamine-decongestant combination effective in temporarily relieving symptoms ofthe common cold in preschool children?
S.D.Ü. Tıp pak.
Derg
. 2010:17(4)/ 25-28
Akcan,
Col
d medications.
29
JPediatr
1997
; 130: 463-466.
25. HuttonN, Wilson MH, Mellits D, et al. Effectiveness ofan antihistamine-decongestant combination for young children with the common cold: a randomized, controlledclinicaltrial.JPediatr 1991;118:125-130.
26. Taylor JA, Novack AH, Almquist JR, Rogers JE. Efficacy of cough suppressants in children. J Pediatr 1993; 122: 799-802.
27. Rostagno C, Caciolli S, Felici M, Gori F, Neri Serneri GG. Dilated cardiomyopathy associated with chronic consumption ofphendimetrazine. Am Heart J 1996; 131: 407-409.
28. Cetaruk EW, Aaron CK. Hazards ofnonprescription medications. Emerg Med ClinNorthAm 1994; 12: 483-510.
29. Pentel P. Toxicity ofover-the-counter stimulants. JAMA 1984;252: 1898-1903.
30. Glick R, Hoying J, Cerullo L, Perlman S. Phenylpropanolamine: an over-the-counter drug causing central nervous system vasculitis and intracerebral hemorrhage. Case report and review. Neurosurgery 1987; 20: 969-974.
31. Kase CS, Foster TE, Reed JE, Spatz El, Girgis GN. Intracerebral hemorrhage and phenylpropanolamine use. Neurology 1987; 37: 399-404.
32. Burton BT, Rice M, Schmertzler LE. Atrioventricular block following overdose ofdecongestant cold medication. J Emerg Med 1985; 2: 415- 419.
33. Lake CR, Gallant S, Masson E, Miller P. Adverse drug effects attributed to phenylpropanolamine: a review of 142 case reports. Am J Med 1990; 89: 195-208.
34. Conway EE, Walsh CA, Palomba AL. Supraventricular tachycardia following the administration of phenylpropanolamine in an infant. Pediatr Emerg Care 1989; 5: 173-174.
35. Weesner KM, Denison M, Roberts RJ. Cardiac arrhythmias in an adolescent following ingestion of an over-the-counter stimulant. Clin Pediatr 1982; 21: 700-701.
36. Veronica L. Gunn, Samina H. Taha, Erica L. Liebelt and Janet R. Serwint. Toxicity of Over-the-Counter Cough and Cold Medications. Pediatrics 2001; 108:
52-57.
37. Litovitz T, Manoguerra A. Comparison ofpediatric poisoning hazards: an analysis of3.8 million exposure incidents. Pediatrics 1992; 89: 999-1006.
38. Rivera-Penera T, Gugig R, Davis J, et al. Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity. J Pediatr 1997; 130: 300-304.
39. Holt GA, Hollon JD, Hughes SE, Coyle R. OTC labels: can consumers read and understand them ? Am Pharm 1990;NS30: 51-54.
40. Kapasi AA, Lorin MI, Nirken MH, Yudovich M. Parents' knowledge and sources ofknowledge about
antipyreticdrugs.JPediatr 1980; 97: 1035-1037.
41. Bradley CP, Riaz A, Tobias RS, Kenkre JE, Dassu DY. Patient attitudes to over-the-counter drugs and possible professional responses to self-medication. Fam Pract 1998; 15: 44-50.
42. Dart RC, Paul IM, Bond GR, Winston DC, Manoguerra AS, Palmer RB, et al. Pediatric fatalities associated with over the counter (nonprescription) cough and cold medications. Ann Emerg Med 2009;53: 411-417.
43. Health Canada (website). Health Canada's decision on cough and cold medicines. Ottawa, ON: Health
Canada;2008.
44. wwwhc-sc.gc.ca/ahc-asc/media/advisories-avis/_2008/2008_184info1-eng.php.
45. Food and Drug Administration. Using over-the counter cough and cold products in children. Silver Spring. MD: Food and Drug Administration;2008. www.fda.gov/ForConsumers/ConsumerUpdates/ucm 048515.htm.
46. Shefrin AE, Godman RD. Use ofover-the-counter cough and cold medications in children. Can Fam Physician2009;55: 1081-1083.
47. Vassilev ZP, Kabadi S, Villa R. Safety and efficacy of over-the-counter cough and cold medicines for use in children. Expert Opin Drug Saf2010;9: 233-242.

Thank you for copying data from http://www.arastirmax.com